Search research articles
Contact Us
Filters
Showing results (261-270 of 282) with videos related to
Page
of 29
Sort By:
Lancet (London, England)
|
July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, et al.
Cancer Letters
|
June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center Study
Amgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 11, 2024
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral
Stephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Roshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 15, 2018
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018
David S Ettinger, Dara L Aisner, Douglas E Wood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Nature Communications
|
April 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights
Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.
Cell Reports. Medicine
|
March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Nature Communications
|
July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 282) with videos related to
Sort By:
Page
of 29
Lancet (London, England)
|
July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, et al.
Cancer Letters
|
June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center Study
Amgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 11, 2024
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral
Stephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 8, 2021
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Roshal R Patel, Kewen He, Hampartsoum B Barsoumian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 15, 2018
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018
David S Ettinger, Dara L Aisner, Douglas E Wood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Nature Communications
|
April 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights
Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.
Cell Reports. Medicine
|
March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Nature Communications
|
July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.
Page
of 29